Cart
sales@molnova.com
NXY-059
CAS No. 168021-79-2
NXY-059 ( NXY 059;NXY059;Disufenton sodium )
Catalog No. M12566 CAS No. 168021-79-2
NXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 33 | In Stock |
|
| 10MG | 54 | In Stock |
|
| 25MG | 106 | In Stock |
|
| 50MG | 195 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 200MG | 524 | In Stock |
|
| 500MG | 822 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNXY-059
-
NoteResearch use only, not for human use.
-
Brief DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
-
DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo; exhibits a substantial protective effect, lessening the disability caused by an experimentally induced stroke in a primate species, shows significantly decreased neurological impairment in rat model of hemorrhagic stroke.Stroke Phase 3 Discontinued
-
SynonymsNXY 059;NXY059;Disufenton sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number168021-79-2
-
Formula Weight381.33
-
Molecular FormulaC11H13NNa2O7S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+]
-
Chemical Name1,3-Benzenedisulfonic acid, 4-[[(1,1-dimethylethyl)oxidoimino]methyl]-, sodium salt (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marshall JW, et al. Stroke. 2001 Jan;32(1):190-8.
2. Kuroda S, et al. J Cereb Blood Flow Metab. 1999 Jul;19(7):778-87.
3. Peeling J, et al. Neuropharmacology. 2001 Mar;40(3):433-9.
4. Sydserff SG, et al. Br J Pharmacol. 2002 Jan;135(1):103-12.
2. Kuroda S, et al. J Cereb Blood Flow Metab. 1999 Jul;19(7):778-87.
3. Peeling J, et al. Neuropharmacology. 2001 Mar;40(3):433-9.
4. Sydserff SG, et al. Br J Pharmacol. 2002 Jan;135(1):103-12.
molnova catalog
related products
-
pep2-SVKI
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).
-
ML226
ML226 is a α/β hydrolase domain-containing protein 11 (ABHD11) inhibitor that inhibits ABHD11 in vitro and in situ.
-
6-chloro-1-ethyl-7-(...
6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid is a compound used as a molecular building block.
